Antibacterial alternative to antibiotics with high specificity against Escherichia coli

Summary:

A Spanish university has modified several phage proteins (Poll-N and UK-C) that have high specificity against Escherichia coli (E. coli), but not against other Gram-negative bacteria. They could be used in the case of contaminated food, cosmetics or water, or even in the treatment of diseases (infections) caused by E. coli. Biotechnological or pharmaceutical companies interested in the commercial exploitation of the technology through license and/or technical cooperation agreements are sought.

Reference: TOES20200113001

Country: Spain

Submitted: 17. 2. 2020

View Partnering Opportunity

Keywords

Technology: Virus, Virology/Antibiotics/Bacteriology; Cellular and Molecular Biology

Market: Cellular and Molecular Biology; Genetic Engineering; Anatomy, Pathology, Immunology, Physiology; Pharmaceuticals/fine chemicals

NACE: Research and experimental development on biotechnology; Other research and experimental development on natural sciences and engineering; Tertiary education

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.